Lyell Immunopharma, Inc. Balance Sheet

Balance Sheet Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Current Assets
Cash & Equivalents 96.67M140.41M293.83M123.55M145.65M105.60M
Prepaid Assets 4.93M11.49M11.14M8.46M9.07M
Current Assets 617.55M626.29M651.29M554.69M379.59M
Non-Current Assets
Property, Plant & Equipment (Net) 77.05M120.10M123.02M102.65M48.20M
Long-Term Investments 83.45M283.53M70.12M32.00M19.00M
Other Non-Current Assets 1.80M0.47M0.47M0.28M4.24M4.62M
Non-Current Assets 290.73M501.12M286.27M195.34M111.27M
Assets 908.28M1,127.41M937.56M750.03M490.86M
Liabilities
Current Liabilities
Accounts Payables 9.40M3.21M3.92M4.82M5.37M
Payables 9.40M3.21M3.92M4.82M5.37M
Accumulated Expenses 28.02M29.06M28.75M28.13M40.82M
Current Deferred Revenue 45.00M6.09M4.99M
Total Current Liabilities 49.28M46.74M37.03M34.52M53.79M
Non-Current Liabilities
Non-Current Deffered Revenue 89.07M79.67M
Preferred Stock Liabilities 519.16M1,010.97M
Operating Leases 50.96M66.65M63.17M56.89M50.99M
Other Non-Current Liabilities 0.53M4.57M4.11M3.66M3.25M
Total Non-Current Liabilities 189.31M193.05M100.20M91.41M104.78M
Total Liabilities 189.84M197.62M104.31M95.08M108.03M
Shareholder's Equity
Common Equity -111.11M-292.53M929.79M833.25M654.95M382.82M
Shareholder's Equity -111.11M-292.53M929.79M833.25M654.95M382.82M
Liabilities and Shareholders Equity 908.28M1,127.41M937.56M750.03M490.86M
Retained Earnings -334.14M-584.36M-767.48M-1002.11M-1345.11M
Treasury Shares 2.03M2.60M0.87M2.07M0.28M
Shares Outstanding 11.18M15.57M242.74M